• The Merits of Data Sharing in Tackling Rare Diseases

    Bio-IT World | BOSTON—Alex Sherman, director of systems in neurology at Massachusetts General Hospital (MGH) presented promising new initiatives in the battle against rare diseases at the Bio-IT World Conference. Sherman proposed a model for dealing with the many obstacles that confront research on rare diseases. 

    May 7, 2012

  • Biosimilars Gain Ground in Europe

    Forbes | Thanks to enabling legislation and differing clinical trials requirements, Europe moves further ahead in biosimilar sales.

    May 7, 2012

  • Dagdigian’s Trends in IT Highlight Bio-IT World Expo

    Bio-IT World | BOSTON—“Filter my words accordingly; I’m not a pundit or visionary,” began Chris Dagdigian in a superfluous introduction to his annual “trends in the trenches” review at the Bio-IT World Expo last week. 

    May 3, 2012

  • Oxford Nanopore Announces a Further $50 Million fundraising

    Bio-IT World | Oxford Nanopore has raised an additional $50 million from private investors as it seeks to build up the commercial and manufacturing infrastructure in preparation for commercial launch of its next-gen sequencing system later this year.  

    May 3, 2012

  • May Free Trials & Downloads

     Bio-IT World | Free trials and downloads for May. 

    May 3, 2012

  • Big Pharma and Rare Diseases: Finding a Balance

    Forbes | Rare diseases affect fewer than 200,000 individuals, but the small consumer pool hasn't negated research for these diseases, rather good drugs for rare diseases can make pharma companies quite a lot of money. Finding a balance between the profits and patients, though, is always a bit tricky.

    May 3, 2012

  • GSK, Yale Enter Drug Discovery Collaboration

    Hartford Business Journal | GlaxoSmithKline and Yale have entered a new drug discovery partnership focused on potential medications to target disease-causing proteins. 

    May 3, 2012

  • Biotech's Takeover Protection Thanks to a Few Big Investors

    Reuters | Biotech's ability to fight off Big Pharma is due to a handful of large investors that dominate the companies' shares registries.

    May 2, 2012

  • The Off-Label Drug War of Words

    Bio-IT World | The Skeptical Outsider | If knowledge is power and ignorance is bliss, what is power used to prevent knowledge from eliminating ignorance? I don’t know; ask the FDA. 

    May 1, 2012

  • UC Santa Cruz Launches Cancer Genomics Hub

    UC Santa Cruz | The University of California, Santa Cruz has established the Cancer Genomics Hub (CGHub), a large-scale data repository and user portal for the National Cancer Institute's cancer genome research programs. 

    May 2, 2012

  • IBM Cloud Used to Track Counterfeit Drugs

    eWeek | IBM and Sproxil have teamed up to use IBM's visualization, analytics, and cloud capabilities to detect and prevent drug counterfeiting. Sproxil provides patients with verification of a drug's authenticity via free text message. 

    May 1, 2012

  • Bina Technologies Wants to Remake Genome Analysis

    GigaOM | Stanford spin-out Bina Technologies emerged from stealth mode last week at the Bio-IT World Expo, aiming to bring an Apple-like business model to genomics with a unique combination of hardware and cloud technologies.  

    May 1, 2012

  • Eric Perakslis’ Informatics Prescription for FDA

    Bio-IT World | BOSTON—Eric Perakslis, recently installed as the chief information officer and chief scientist (informatics) at the U.S. Food and Drug Administration (FDA), gave delegates at the Bio-IT World Conference a snapshot of his new role at the agency. 

    Apr 30, 2012

  • A Broad Perspective on Genome Data at Bio-IT World Expo

    Bio-IT World | BOSTON—Jill Mesirov and Martin Leach—the Broad Institute’s chief informatics and chief information officers, respectively—stressed themes of integrative biology and big data in a twin-bill opening keynote session at the 10th anniversary Bio-IT World Conference & Expo last week. 

    Apr 30, 2012

  • April New Products

    Bio-IT World | A summary of the new products in bio-IT released in the past month--from new hybrid-core computers, to NGS software, to qPCR tools, to clinical trial management--many of which were announced at the Bio-IT World Conference & Expo. 

    Apr 30, 2012

  • Bio-IT World News Briefs: April

    Bio-IT World | Bio-IT World’s 10th Anniversary Conference and Expo wrapped up yesterday in Boston. With a record-breaking more than 2,500 attendees, the event was packed with great speakers and events. Here’s a roundup of some of the announcements and stories to come out of the event and elsewhere over the past month. 

    Apr 26, 2012

  • Open Source Health Data Repository Launched

    Nature | A project based in Kansas City, Missouri, aims to create the world's largest pool of open data about health and genomics. The data themselves will come from a variety of sources including consumer-reported direct-to-consumer genomic testing results.

    Apr 26, 2012

  • Heng Li Credits Durbin Pedigree in Accepting Franklin Award

    Bio-IT World | The Broad Institute's Heng Li became the fourth former member of the Richard Durbin lab at the Wellcome Trust Sanger Institute to win the Benjamin Franklin Award for bioinformatics, presented this week at the Bio-IT World Expo.  

    Apr 26, 2012

  • 2012 Best of Show Winners

    Bio-IT World | Bio-IT World announced the winners of the Best of Show competition yesterday evening at the 2012 Bio-IT World Conference & Expo in Boston. Recentris, Opscode, Clear Trial, and Cambridge Semantics were honored. 

    Apr 26, 2012

  • Illumina Announces Basespace Genomic App Store

    Xconomy | Illumina announced an open platform for genomic apps at the Bio-IT World Conference & Expo yesterday. Basespace Apps will use the Amazon cloud and let users download various genomic software options. 

    Apr 25, 2012